文献速递神经核医学肿瘤 PET/CT

基于影像组学建模预测轻度认知障碍向阿尔茨海默病的个体化进展

Using radiomics-based modelling to predict individual progression from mild cognitive impairment to Alzheimer's disease.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2022-01-15

本研究收集华山医院、宣武医院及ADNI数据库共884例受试者的FDG PET与神经心理数据,从80个感兴趣区提取34400个影像组学特征,构建影像组学预测模型(RPM)并在ADNI数据集验证。验证集中RPM模型的Harrell一致性系数为0.703±0.002,优于临床模型(0.632±0.006)和SUVR模型(0.683±0.009);多数关键影像生物标志物在不同认知阶段差异显著并与认知疾病严重程度显著相关。结论认为RPM方法有潜力监测AD高危人群的疾病进展。

要点

  • RPM Cox模型验证集Harrell一致性系数0.703±0.002,优于临床模型0.632±0.006和SUVR模型0.683±0.009。
  • 从80个ROI提取34400个影像组学特征,构建并验证RPM模型。
  • 多数关键影像生物标志物在不同认知阶段差异显著且与认知疾病严重程度显著相关。

核心结论

  • 初步结果表明所开发的RPM方法有潜力监测AD高危人群的疾病进展。

研究设计与样本

  • 收集华山医院、宣武医院及ADNI数据库共884例受试者的FDG PET与神经心理数据。
  • 从80个ROI提取34400个影像组学特征,拼接后进行特征选择,构建RPM模型并在ADNI数据集验证。
  • 另用临床数据和常规半定量指标SUVR建立临床与SUVR Cox模型以作比较。
  • 使用本地医院FDG图像在健康对照及不同认知水平的独立队列(完整AD连续谱)中探索RPM表现。
  • 对影像组学生物标志物与神经心理评估进行相关性分析。

主要发现

  • 验证数据集中RPM Cox模型的Harrell一致性系数为0.703±0.002,临床模型为0.632±0.006,SUVR模型为0.683±0.009。
  • RPM Cox模型的预测性能优于其他Cox模型。
  • 多数关键影像生物标志物在不同认知阶段差异显著,并与认知疾病严重程度显著相关。

关键数值与推荐

  • RPM模型验证集Harrell一致性系数0.703±0.002。
  • 临床模型Harrell一致性系数0.632±0.006。
  • SUVR模型Harrell一致性系数0.683±0.009。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Predicting the risk of disease progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD) has important clinical significance. This study aimed to provide a personalized MCI-to-AD conversion prediction via radiomics-based predictive modelling (RPM) with multicenter 18F-fluorodeoxyglucose positron emission tomography (FDG PET) data. METHOD: FDG PET and neuropsychological data of 884 subjects were collected from Huashan Hospital, Xuanwu Hospital, and from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. First, 34,400 radiomic features were extracted from the 80 regions of interest (ROIs) for all PET images. These features were then concatenated for feature selection, and an RPM model was constructed and validated on the ADNI dataset. In addition, we used clinical data and the routine semiquantification index (standard uptake value ratio, SUVR) to establish clinical and SUVR Cox models for further comparison. FDG images from local hospitals were used to explore RPM performance in a separate cohort of individuals with healthy controls and different cognitive levels (a complete AD continuum). Finally, correlation analysis was conducted between the radiomic biomarkers and neuropsychological assessments. RESULTS: The experimental results showed that the predictive performance of the RPM Cox model was better than that of other Cox models. In the validation dataset, Harrell's consistency coefficient of the RPM model was 0.703 ± 0.002, while those of the clinical and SUVR models were 0.632 ± 0.006 and 0.683 ± 0.009, respectively. Moreover, most crucial imaging biomarkers were significantly different at different cognitive stages and significantly correlated with cognitive disease severity. CONCLUSION: The preliminary results demonstrated that the developed RPM approach has the potential to monitor progression in high-risk populations with AD.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Jiang J, Wang M, Alberts I, et al. Using radiomics-based modelling to predict individual progression from mild cognitive impairment to Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2022. PMID: 35032179. doi:10.1007/s00259-022-05687-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。